Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes

Mingyang Wang,* Yi Zhang,* Lu Feng, Ji Zheng, Shujie Fan, Junya Liu, Nan Yang, Yanyong Liu, Pingping Zuo Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China *These authors contributed equally to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y, Zuo P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/8a75a8b962e343e186ee3787bc7cf4f3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8a75a8b962e343e186ee3787bc7cf4f3
record_format dspace
spelling oai:doaj.org-article:8a75a8b962e343e186ee3787bc7cf4f32021-12-02T06:26:01ZCompound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes1178-2021https://doaj.org/article/8a75a8b962e343e186ee3787bc7cf4f32017-03-01T00:00:00Zhttps://www.dovepress.com/compound-porcine-cerebroside-and-ganglioside-injection-attenuates-cere-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Mingyang Wang,* Yi Zhang,* Lu Feng, Ji Zheng, Shujie Fan, Junya Liu, Nan Yang, Yanyong Liu, Pingping Zuo Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China *These authors contributed equally to this work Background: Compound porcine cerebroside and ganglioside injection (CPCGI) is a neurotrophic drug used clinically to treat certain functional disorders of brain. Despite its extensive usage throughout China, the exact mechanistic targets of CPCGI are unknown. This study was carried out to investigate the protective effect of CPCGI against ischemic neuronal damage in rats with middle cerebral artery occlusion (MCAO) reperfusion injury and to investigate the neuroprotective mechanisms of CPCGI. Materials and methods: Adult male Sprague-Dawley rats were subjected to MCAO surgery for 2 hours followed by reperfusion. The rats were administered CPCGI once a day for 14 days after reperfusion, and behavioral tests were performed 1, 3, 7, and 14 days post MCAO. Hematoxylin–eosin staining was used to measure infarct volume, and immunohistochemical analysis was performed to determine the number of NeuN-positive neurons in the ischemic cortex penumbra. Finally, the relative expression levels of proteins associated with apoptosis (Bcl-2, Bax, and GADD45α), synaptic function (Synaptophysin, SNAP25, Syntaxin, and Complexin-1/2), and mitochondrial function (KIFC2 and UCP3) were determined by Western blot. Results: CPCGI treatment reduced infarct size, decreased neurological deficit scores, and accelerated the recovery of somatosensory function 14 days after MCAO. In addition, CPCGI reduced the loss of NeuN-positive cells in the ischemic cortex penumbra. In the ischemic cortex, CPCGI treatment decreased GADD45α expression, increased the Bcl-2/Bax ratio, augmented Synaptophysin, SNAP25, and Complexin-1/2 expression, and increased the expression of KIFC2 and UCP3 compared with sham rats 14 days after MCAO reperfusion injury. Conclusion: CPCGI displays neuroprotective properties in rats subjected to MCAO injury by inhibiting apoptosis and improving synaptic and mitochondrial function. Keywords: compound porcine cerebroside and ganglioside injection, cerebral ischemia reperfusion, multitarget, neuroprotectionWang MZhang YFeng LZheng JFan SLiu JYang NLiu YZuo PDove Medical PressarticleCompound Porcine Cerebroside and Ganglioside Injectioncerebral ischemia reperfusionmulti-targetneuroprotectionNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 927-935 (2017)
institution DOAJ
collection DOAJ
language EN
topic Compound Porcine Cerebroside and Ganglioside Injection
cerebral ischemia reperfusion
multi-target
neuroprotection
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Compound Porcine Cerebroside and Ganglioside Injection
cerebral ischemia reperfusion
multi-target
neuroprotection
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Wang M
Zhang Y
Feng L
Zheng J
Fan S
Liu J
Yang N
Liu Y
Zuo P
Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
description Mingyang Wang,* Yi Zhang,* Lu Feng, Ji Zheng, Shujie Fan, Junya Liu, Nan Yang, Yanyong Liu, Pingping Zuo Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China *These authors contributed equally to this work Background: Compound porcine cerebroside and ganglioside injection (CPCGI) is a neurotrophic drug used clinically to treat certain functional disorders of brain. Despite its extensive usage throughout China, the exact mechanistic targets of CPCGI are unknown. This study was carried out to investigate the protective effect of CPCGI against ischemic neuronal damage in rats with middle cerebral artery occlusion (MCAO) reperfusion injury and to investigate the neuroprotective mechanisms of CPCGI. Materials and methods: Adult male Sprague-Dawley rats were subjected to MCAO surgery for 2 hours followed by reperfusion. The rats were administered CPCGI once a day for 14 days after reperfusion, and behavioral tests were performed 1, 3, 7, and 14 days post MCAO. Hematoxylin–eosin staining was used to measure infarct volume, and immunohistochemical analysis was performed to determine the number of NeuN-positive neurons in the ischemic cortex penumbra. Finally, the relative expression levels of proteins associated with apoptosis (Bcl-2, Bax, and GADD45α), synaptic function (Synaptophysin, SNAP25, Syntaxin, and Complexin-1/2), and mitochondrial function (KIFC2 and UCP3) were determined by Western blot. Results: CPCGI treatment reduced infarct size, decreased neurological deficit scores, and accelerated the recovery of somatosensory function 14 days after MCAO. In addition, CPCGI reduced the loss of NeuN-positive cells in the ischemic cortex penumbra. In the ischemic cortex, CPCGI treatment decreased GADD45α expression, increased the Bcl-2/Bax ratio, augmented Synaptophysin, SNAP25, and Complexin-1/2 expression, and increased the expression of KIFC2 and UCP3 compared with sham rats 14 days after MCAO reperfusion injury. Conclusion: CPCGI displays neuroprotective properties in rats subjected to MCAO injury by inhibiting apoptosis and improving synaptic and mitochondrial function. Keywords: compound porcine cerebroside and ganglioside injection, cerebral ischemia reperfusion, multitarget, neuroprotection
format article
author Wang M
Zhang Y
Feng L
Zheng J
Fan S
Liu J
Yang N
Liu Y
Zuo P
author_facet Wang M
Zhang Y
Feng L
Zheng J
Fan S
Liu J
Yang N
Liu Y
Zuo P
author_sort Wang M
title Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
title_short Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
title_full Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
title_fullStr Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
title_full_unstemmed Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
title_sort compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/8a75a8b962e343e186ee3787bc7cf4f3
work_keys_str_mv AT wangm compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT zhangy compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT fengl compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT zhengj compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT fans compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT liuj compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT yangn compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT liuy compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
AT zuop compoundporcinecerebrosideandgangliosideinjectionattenuatescerebralischemiandashreperfusioninjuryinratsbytargetingmultiplecellularprocesses
_version_ 1718399947616813056